National Coverage Determination (NCD) 160.18 Vagus Nerve Stimulation (VNS)

Change Request (CR) 11461 notifies MACs that effective for claims with dates of service on or after February 15, 2019, the Centers for Medicare & Medicaid Services (CMS) will cover Food and Drug Administration (FDA) approved vagus nerve stimulation (VNS) devices for treatment resistant depression (TRD) through Coverage with Evidence Development (CED) for patients that meet specific conditions of coverage and criteria.

Last Updated: 06/25/2020